Get the Stockscreener App
18.81
1.26%
-0.24
Inmode Ltd stock is traded at $18.81, with a volume of 1.08M.
It is down -1.26% in the last 24 hours and up +17.05% over the past month.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF and Morpheus8. The majority of its revenue comes from the United States.
See More
Previous Close:
$19.05
Open:
$18.48
24h Volume:
1.08M
Relative Volume:
1.20
Market Cap:
$1.31B
Revenue:
$492.05M
Net Income/Loss:
$197.92M
P/E Ratio:
8.1783
EPS:
2.3
Net Cash Flow:
$176.12M
1W Performance:
+4.27%
1M Performance:
+17.05%
6M Performance:
+19.20%
1Y Performance:
-17.86%
1-Day Range:
$18.45
$19.06
1-Week Range:
$18.18
$19.07
52-Week Range:
$14.87
$24.03
Inmode Ltd Stock (INMD) Company Profile
Compare INMD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
INMD
Inmode Ltd
|
18.81 | 1.31B | 492.05M | 197.92M | 176.12M | 2.30 |
|
ABT
Abbott Laboratories
|
130.61 | 226.54B | 41.95B | 13.40B | 6.49B | 7.65 |
|
BSX
Boston Scientific Corp
|
106.11 | 156.39B | 16.75B | 1.85B | 1.89B | 1.25 |
|
SYK
Stryker Corp
|
385.18 | 146.98B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
92.81 | 119.01B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
76.19 | 44.94B | 5.72B | 4.17B | 490.10M | 6.97 |
Inmode Ltd Stock (INMD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-17-24 | Initiated | BTIG Research | Buy |
| Jul-23-24 | Downgrade | Jefferies | Buy → Hold |
| Nov-03-23 | Downgrade | UBS | Buy → Neutral |
| Oct-13-23 | Downgrade | Canaccord Genuity | Buy → Hold |
| Mar-29-23 | Initiated | UBS | Buy |
| Feb-17-23 | Downgrade | Needham | Buy → Hold |
| Dec-21-22 | Initiated | Barclays | Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| May-25-21 | Initiated | Barclays | Overweight |
| May-18-21 | Initiated | Needham | Buy |
| Sep-03-19 | Initiated | Barclays | Overweight |
| Sep-03-19 | Initiated | Canaccord Genuity | Buy |
| Sep-03-19 | Initiated | Robert W. Baird | Outperform |
| Sep-03-19 | Initiated | UBS | Buy |
View All
Inmode Ltd Stock (INMD) Latest News
InMode Ltd. (NASDAQ:INMD) Stock Holdings Lessened by DDD Partners LLC - MarketBeat
DEADLINE ALERT: Bernstein Liebhard LLP Reminds InMode Ltd. Investors of Upcoming Deadline - ACCESS Newswire
InMode (NASDAQ:INMD) Shares Gap DownWhat's Next? - MarketBeat
INMD INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Reminds InMode Ltd. Investors to Join the Class Action Lawsuit! - ACCESS Newswire
InMode Ltd. (NASDAQ:INMD) Q4 2024 Earnings Call Transcript - MSN
Investigation announced for Investors in InMode Ltd. (NASDAQ: INMD) over possible Wrongdoing - openPR
InMode: Plastic Surgery Boom, Cash Flow, And Cheap (NASDAQ:INMD) - Seeking Alpha
InMode (NASDAQ:INMD) Updates FY25 Earnings Guidance - MarketBeat
Barclays Issues Positive Forecast for InMode (NASDAQ:INMD) Stock Price - MarketBeat
InMode's (INMD) "Hold" Rating Reiterated at Needham & Company LLC - MarketBeat
InMode (INMD) Expected to Announce Earnings on Tuesday - MarketBeat
InMode Ltd. (NASDAQ:INMD) Shares Sold by Boston Trust Walden Corp - MarketBeat
InMode reports revenue dip, plans share repurchase - MSN
InMode (INMD) Q4 2024 Earnings Call Transcript - Mitrade
InMode’s 2024 Financial Results and Strategic Moves - TipRanks
With 55% institutional ownership, InMode Ltd. (NASDAQ:INMD) is a favorite amongst the big guns - Simply Wall St
Earnings call transcript: InMode Q4 2024 results miss forecasts - MSN
Earnings call transcript: InMode Q4 2024 results miss forecasts By Investing.com - Investing.com UK
InMode Ltd (INMD) Q4 2024 Earnings Report Preview: What To Expect - Yahoo Finance
InMode Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance
InMode reports revenue dip, plans share repurchase By Investing.com - Investing.com South Africa
InMode Ltd. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024 - Marketscreener.com
InMode: Q4 Earnings Snapshot - The Washington Post
InMode Reports Fourth Quarter and Full Year 2024 Financial Resul - GuruFocus.com
InMode earnings missed by $0.17, revenue fell short of estimates - Investing.com India
Inmode Reports Q4 And FY 2024 Results; Board Approves New Share Repurchase Program - Marketscreener.com
InMode Reports Decrease in 2024 Revenues, Announces New Share Repurchase Program - TipRanks
INMODE Earnings Results: $INMD Reports Quarterly Earnings - Nasdaq
Earnings Flash (INMD) INMODE LTD. Posts Q4 Adjusted EPS $0.42, vs. FactSet Est of $0.53 - Marketscreener.com
InMode: Q4 Earnings Snapshot -February 04, 2025 at 07:17 am EST - Marketscreener.com
InMode Reports Fourth Quarter and Full Year 2024 Financial Results; Board of Directors Has Approved a New Share Repurchase Program - PR Newswire
InMode to Participate in the BTIG MedTech, Digital Health, Life Sciences & Diagnostics Tools Conference - StreetInsider.com
InMode Investor Alert: Exclusive Access to CFO at Major Healthcare Conference - StockTitan
InMode Ltd. (NASDAQ:INMD) Stake Cut by SG Americas Securities LLC - MarketBeat
[Latest] Global Cosmetic Surgery Market Size/Share Worth USD 207.6 Billion by 2033 at a 11.7% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value) - GlobeNewswire Inc.
InMode Ltd. (NASDAQ:INMD) Receives $22.40 Consensus Target Price from Brokerages - MarketBeat
Inmode Ltd Stock (INMD) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.61%
1.47%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):